Topic: Payment & Reimbursement
-
Fact Checking the NYT Fact Check on the Trump Proposal
Read More
-
A $475,000 price tag for a new cancer drug: crazy or meh?
Read More
-
The Conflict Between QALYs and Well-Funded Patient Advocacy Groups
Read More
-
Remdesivir Less Expensive for “Government Programs”? Not So Fast.
Read More
-
Blueprints for Indication-Specific Pricing
Read More
-
Pharmaceutical Products and Their Value
Read More
-
Medicare Negotiation: A “Too Little” or “Too Late” Framework for Drug Selection
Read More
-
Abandon Biosimilars as Biologics are Natural Monopolies
Read More
-
List Price, Net Price, and the Rebate Caught in the Middle
Read More
-
Overview of Original Subscription Model and Features of LA and WA Proposals
Read More